Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Mar:78:19-29.
doi: 10.1016/j.brat.2015.11.015. Epub 2015 Dec 15.

A randomized clinical trial of a tailored behavioral smoking cessation preparation program

Affiliations
Randomized Controlled Trial

A randomized clinical trial of a tailored behavioral smoking cessation preparation program

Danielle E McCarthy et al. Behav Res Ther. 2016 Mar.

Abstract

Despite considerable progress in reducing cigarette smoking prevalence and enhancing smoking cessation treatments, most smokers who attempt to quit relapse. The current randomized clinical trial evaluated the efficacy of an adjunctive behavioral smoking cessation treatment based on learning theory. Adult daily smokers were randomly assigned to standard treatment (N = 47) with nicotine patch and individual counseling or to standard treatment plus a "practice quitting" program involving seven sessions of escalating prescribed abstinence periods (N = 46) prior to a target stop smoking date. Practice quitting was designed to extinguish smoking in response to withdrawal symptoms. Retention in treatment was excellent and the treatment manipulation increased the interval between cigarettes across practice quitting sessions on average by 400%. The primary endpoint, seven-day point-prevalence abstinence four weeks post-quit, was not significantly affected by practice quitting (31.9% in the standard treatment condition, 37.0% in the practice quitting condition). Practice quitting increased latency to a first lapse among those who quit smoking for at least one day and prevented progression from a first lapse to relapse (smoking daily for a week) relative to standard treatment, however. Practice quitting is a promising adjunctive treatment in need of refinement to enhance adherence and efficacy.

Keywords: Behavioral treatment; Randomized clinical trial; Smoking cessation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CONSORT 2010 Flow Diagram.
Figure 2
Figure 2
Abstinence duration (minutes) for individual subjects in the control and practice quitting conditions.
Figure 3
Figure 3
Mediation model of practice quitting effects on 4-week point-prevalence abstinence. Unconditional model χ2(24)=25.250, p=0.392, RMSEA=0.024, CFI=.998 Indirect effect of condition on abstinence through mean abstinence duration=0.032, 95% CI= −0.835, 0.899 Indirect effect of condition on abstinence through abstinence slope=0.103, 95% CI= −0.234, 0.439 * p<.05
Figure 4
Figure 4
Cessation milestones by condition.
Figure 4
Figure 4
Cessation milestones by condition.

References

    1. Abrams DB, Niaura R, Brown RA, Emmons KM, Goldstein MG, Monti PM. The tobacco dependence treatment handbook: A guide to best practices. New York, NY: Guilford Press; 2003.
    1. Allen SS, Bade T, Hatsukami D, Center B. Craving, withdrawal, and smoking urges on days immediately prior to smoking relapse. Nicotine and Tobacco Research. 2008;10:35–45. doi: 10.1080/14622200701705076. - DOI - PubMed
    1. Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC. Addiction motivation reformulated: An affective processing model of negative reinforcement. Psychological Review. 2004;111:33–51. doi: 10.1037/0033-295X.111.1.33. - DOI - PubMed
    1. Baker TB, Piper ME, McCarthy DE, Bolt DM, Smith SS, … Toll BA. Time to first cigarette in the morning as an index of ability to quit smoking: Implications for nicotine dependence. Nicotine and Tobacco Research. 2007;9:S555–S570. doi: 10.1080/14622200701673480. - DOI - PMC - PubMed
    1. Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive behavioral therapy, imipramine, or their combination for panic disorder. JAMA. 2000;283:2592–2450. doi: 10.1001/jama.283.19.2529. - DOI - PubMed

Publication types